Literature DB >> 1969839

The gene causing familial hypoalphalipoproteinemia is not caused by a defect in the apo AI-CIII-AIV gene cluster in a Spanish family.

J J Kastelein1, J L Haines, M R Hayden.   

Abstract

High-density lipoprotein (HDL) cholesterol levels have an inverse relationship with the frequency of coronary and cerebrovascular disease. Most commonly HDL deficiency is environmentally modulated. Familial hypoalphalipoproteinemia (FHA) is a genetically determined HDL deficiency disease, in all likelihood transmitted as an autosomal dominant trait and associated with premature atherosclerosis. Apolipoprotein AI (apo AI) is the major apoprotein in the HDL particle, and defects in this protein have been suggested as the cause of FHA. We have identified a large family of Spanish descent with FHA and performed genetic linkage analysis using restriction fragment length polymorphisms in the Apo AI-CIII-AIV gene cluster to test this hypothesis. Results in this family formally exclude the apo AI-CIII-AIV gene cluster as the site for the mutation underlying FHA.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 1969839     DOI: 10.1007/bf00195807

Source DB:  PubMed          Journal:  Hum Genet        ISSN: 0340-6717            Impact factor:   4.132


  23 in total

1.  A comprehensive evaluation of the heparin-manganese precipitation procedure for estimating high density lipoprotein cholesterol.

Authors:  G R Warnick; J J Albers
Journal:  J Lipid Res       Date:  1978-01       Impact factor: 5.922

2.  Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge.

Authors:  W T Friedewald; R I Levy; D S Fredrickson
Journal:  Clin Chem       Date:  1972-06       Impact factor: 8.327

3.  Estimation of the recombination fraction in human pedigrees: efficient computation of the likelihood for human linkage studies.

Authors:  J Ott
Journal:  Am J Hum Genet       Date:  1974-09       Impact factor: 11.025

4.  Quantitative determination of serum triglycerides by the use of enzymes.

Authors:  G Bucolo; H David
Journal:  Clin Chem       Date:  1973-05       Impact factor: 8.327

5.  Pediatric victims of unexplained stroke and their families: familial lipid and lipoprotein abnormalities.

Authors:  C J Glueck; S R Daniels; S Bates; C Benton; T Tracy; J L Third
Journal:  Pediatrics       Date:  1982-03       Impact factor: 7.124

6.  Plasma-high-density-lipoprotein concentration and development of ischaemic heart-disease.

Authors:  G J Miller; N E Miller
Journal:  Lancet       Date:  1975-01-04       Impact factor: 79.321

7.  Relationship between apolipoproteins and chemical components of lipoproteins in survivors of myocardial infarction.

Authors:  P Avogaro; G B Bon; G Cazzolato; E Rorai
Journal:  Atherosclerosis       Date:  1980-09       Impact factor: 5.162

8.  Fish-eye disease. A new familial condition with massive corneal opacities and dyslipoproteinaemia.

Authors:  L A Carlson; B Philipson
Journal:  Lancet       Date:  1979-11-03       Impact factor: 79.321

9.  Cerebrovascular arteriopathy (arteriosclerosis) and ischemic childhood stroke.

Authors:  S R Daniels; S Bates; R R Lukin; C Benton; J Third; C J Glueck
Journal:  Stroke       Date:  1982 May-Jun       Impact factor: 7.914

10.  Strategies for multilocus linkage analysis in humans.

Authors:  G M Lathrop; J M Lalouel; C Julier; J Ott
Journal:  Proc Natl Acad Sci U S A       Date:  1984-06       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.